273 related articles for article (PubMed ID: 14552697)
1. COX-2 and COX-2 enzyme inhibition.
Conti P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):I-II. PubMed ID: 14552697
[No Abstract] [Full Text] [Related]
2. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
[No Abstract] [Full Text] [Related]
3. [Topical pharmacology. COX-2 inhibitors].
Heinzl S
Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
[No Abstract] [Full Text] [Related]
4. [Specific COX-2 inhibitors. Also effective in arthritis?].
Einecke D
MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
[No Abstract] [Full Text] [Related]
5. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
6. An update on specific COX-2 inhibitors: the COXIBs.
Gupta S; Crofford LJ
Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
[No Abstract] [Full Text] [Related]
7. Acute interstitial nephritis and COX-2 inhibition.
Chow KM; Szeto CC; Li P; Lai FM
Hosp Med; 2003 Jul; 64(7):429. PubMed ID: 12886856
[No Abstract] [Full Text] [Related]
8. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
Shi G
Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
[No Abstract] [Full Text] [Related]
9. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
10. New treatment options for Bartter's syndrome.
Kleta R; Basoglu C; Kuwertz-Bröking E
N Engl J Med; 2000 Aug; 343(9):661-2. PubMed ID: 10979805
[No Abstract] [Full Text] [Related]
11. Differences between COX-2-specific inhibitors: clinical and economic implications.
Sonnenblick EH
Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
[No Abstract] [Full Text] [Related]
12. [Selective COX-2 inhibitor. Stomach protection--but not always].
MMW Fortschr Med; 2001 Jun; 143(25):60. PubMed ID: 11469005
[No Abstract] [Full Text] [Related]
13. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache].
MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443
[No Abstract] [Full Text] [Related]
14. HMO drug formulary access increases for COX-2s.
Manag Care; 2002 Oct; 11(10):48. PubMed ID: 12415909
[No Abstract] [Full Text] [Related]
15. New versus old drugs for arthritis.
Health News; 1999 Nov; 5(14):7. PubMed ID: 10624169
[No Abstract] [Full Text] [Related]
16. COX-2 inhibition and the control of pain.
Kiefer W; Dannhardt G
Curr Opin Investig Drugs; 2002 Sep; 3(9):1348-58. PubMed ID: 12498012
[TBL] [Abstract][Full Text] [Related]
17. [COX-2 inhibitors: current status and outlook].
Dannhardt G; Hahn L
Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
[No Abstract] [Full Text] [Related]
18. Cardiovascular thrombotic events and COX-2 inhibitors: results in patients with osteoarthritis receiving rofecoxib.
Bannwarth B; Ravaud P; Dougados M
J Rheumatol; 2003 Feb; 30(2):421-2. PubMed ID: 12583353
[No Abstract] [Full Text] [Related]
19. When to try COX-2-specific inhibitors. Safer than standard NSAIDs in some situations.
Rehman Q; Sack KE
Postgrad Med; 1999 Oct; 106(4):95-7, 101-2, 105-6. PubMed ID: 10533511
[TBL] [Abstract][Full Text] [Related]
20. Second selective COX-2 inhibitor receives marketing approval.
Miller JL
Am J Health Syst Pharm; 1999 Jul; 56(13):1294. PubMed ID: 10683121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
